Rule: 64B13-18.002 Prev   Up   Next

Rule Title: Formulary of Topical Ocular Pharmaceutical Agents
Department: DEPARTMENT OF HEALTH    Add to MyFLRules Favorites
Add to MyFLRules Favorites
Division: Board of Optometry
Chapter: TOPICAL OCULAR PHARMACEUTICAL AGENTS

Latest version of the final adopted rule presented in Florida Administrative Code (FAC):

VIEW_RULE Effective Date: 1/25/2019
History Notes: Rulemaking Authority 463.005, 463.0055(2)(a) FS. Law Implemented 463.0055 FS. History–New 3-30-87, Amended 4-5-88, 5-7-90, Formerly 21-18.002, Amended 5-10-92, 1-29-93, Formerly 21Q-18.002, Amended 8-31-93, 7-30-94, Formerly 61F8-18.002, Amended 2-11-96, 4-21-96, 1-12-97, 6-8-97, Formerly 59V-18.002, Amended 6-15-00, 6-7-05, 6-10-06, 6-26-08, 10-16-08, 3-23-09, 6-28-09, 10-18-09, 4-21-10, 12-26-10, 7-21-11, 11-11-12, 11-29-13, 12-9-13, 4-10-14, 8-14-15, 1-20-17, 8-31-18, 1-25-19.
References in this version: No reference(s).
History of this Rule since Jan. 6, 2006
Notice /
Adopted
Section Description ID Publish
Date
View Text Proposed
64B13-18.002
The purpose of the amendment is to add item to the formulary. 21710654 4/9/2019
Vol. 45/69
View Text Development
64B13-18.002
The purpose of the amendment is to add item to the formulary. 21652260 3/22/2019
Vol. 45/57
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 21361939 Effective:
01/25/2019
View Text Change
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 21003912 10/16/2018
Vol. 44/202
View Text Proposed
64B13-18.002
To add a topical ocular pharmaceutical agent to the formulary. 20918067 9/21/2018
Vol. 44/185
View Text Development
64B13-18.002
The Board proposes the development of a rule amendment to add an item to the TOPA formulary rule. 20854338 9/4/2018
Vol. 44/172
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 20641229 Effective:
08/31/2018
View Text Proposed
64B13-18.002
The Board proposes the rule amendment to add an item to the formulary rule. 20344603 4/26/2018
Vol. 44/82
View Text Development
64B13-18.002
The Board proposes the development of a rule amendment to add an item to the formulary rule. 20283105 4/11/2018
Vol. 44/71
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 18448253 Effective:
01/20/2017
View Text Correction
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 18110111 10/6/2016
Vol. 42/195
View Text Proposed
64B13-18.002
To add item to formulary rule. 18056276 9/27/2016
Vol. 42/188
View Text Development
64B13-18.002
To add item to formulary rule. 17985078 9/9/2016
Vol. 42/176
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 16139556 Effective:
08/14/2015
View Text Proposed
64B13-18.002
To update the concentration percentage of a topical ocular pharmaceutical agent. 15885319 4/13/2015
Vol. 41/71
View Text Development
64B13-18.002
To update the concentration percentage of a topical ocular pharmaceutical agent. 15824888 3/25/2015
Vol. 41/58
View Text Development
64B13-18.002
To add an item to subsection (9). 15722747 2/27/2015
Vol. 41/40
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 14373186 Effective:
04/10/2014
View Text Proposed
64B13-18.002
The Board proposes the rule amendment to add a new agent. 14187722 2/14/2014
Vol. 40/31
View Text Development
64B13-18.002
The Board proposes the rule amendment to add a new agent. 14098579 1/24/2014
Vol. 40/16
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 13874218 Effective:
12/09/2013
View Text Correction
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 13723674 10/25/2013
Vol. 39/209
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 13650148 Effective:
10/20/2013
View Text Proposed
64B13-18.002
The Board proposes the rule amendment to delete unnecessary language and add new language to update the rule in accordance with Chapter 2013-26, Laws of Florida. 13646171 10/8/2013
Vol. 39/196
View Text Development
64B13-18.002
The Board proposes the rule amendment to delete unnecessary language and add new language to update the rule in accordance with Chapter 2013-26, Laws of Florida. 13533748 9/17/2013
Vol. 39/181
View Text Correction
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 13533166 9/17/2013
Vol. 39/181
View Text Proposed
64B13-18.002
The Board proposes the rule amendment to add a new compound to the existing formulary of topical ocular pharmaceutical agents. 13410849 8/21/2013
Vol. 39/163
View Text Development
64B13-18.002
The Board proposes the rule amendment to add a new compound to the existing formulary of topical ocular pharmaceutical agents rule . 13305022 7/29/2013
Vol. 39/146
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 12034322 Effective:
11/11/2012
View Text Change
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 11827227 8/3/2012
Vol. 38/31
View Text Proposed
64B13-18.002
The Board is adding the drug, Natacyn, to the formulary. 11671542 6/29/2012
Vol. 38/26
View Text Development
64B13-18.002
The Board is adding the drug, Natacyn, to the formulary. 11506351 5/18/2012
Vol. 38/20
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 10119833 Effective:
07/21/2011
View Text Proposed
64B13-18.002
The Board is correcting the concentration percentage of Bromfenac, increasing the concentration of Gatifloxacin and adding the anti-allergy medication Alcaftadine. 9924087 5/20/2011
Vol. 37/20
View Text Withdrawal
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 9923796 5/20/2011
Vol. 37/20
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 9363330 Effective:
12/26/2010
View Text Proposed
64B13-18.002
The Board is correcting the concentration percentage of Bromfenac and permits the prescription of a higher concentration of medication. 9434237 12/3/2010
Vol. 36/48
View Text Development
64B13-18.002
The purpose of this rule amendment is to permit the prescription of a higher concentration of the medication. 9342281 11/5/2010
Vol. 36/44
View Text Proposed
64B13-18.002
The Board is correcting the concentration percentage of Bromfenac and the spelling of Nepafenac. 9137708 9/17/2010
Vol. 36/37
View Text Development
64B13-18.002
The Board is correcting the concentration percentage of Bromfenac and the spelling of Nepafenac. 9024218 8/20/2010
Vol. 36/33
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 8513610 Effective:
04/21/2010
View Text Change
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 8344636 3/5/2010
Vol. 36/09
View Text Proposed
64B13-18.002
The Board is adding the drug, Besivance, to the formulary. 8148502 1/15/2010
Vol. 36/02
View Text Development
64B13-18.002
The Board is adding the drug, Resivance, to the formulary. 8024827 12/18/2009
Vol. 35/50
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 7578142 Effective:
10/18/2009
View Text Proposed
64B13-18.002
The purpose of the amendment is to add two additional pharmaceutical agents to the rule, which a certified optometrist is qualified to administer and prescribe in the practice of optometry. 7372696 7/17/2009
Vol. 35/28
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 7302759 Effective:
06/28/2009
View Text Development
64B13-18.002
The purpose of the amendments is to add two additional pharmaceutical agents to the rule, which a certified optometrist is qualified to administer and prescribe in the practice of optometry. 7310131 6/26/2009
Vol. 35/25
View Text Proposed
64B13-18.002
The purpose of the amendment is to correct the maximum permitted concentration of olopatadine. 7082375 5/8/2009
Vol. 35/18
View Text Development
64B13-18.002
The purpose of the amendment is to correct the maximum permitted concentration of olopatadine. 6948224 3/27/2009
Vol. 35/12
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 6906514 Effective:
03/23/2009
View Text Proposed
64B13-18.002
The Board proposes the rule amendment to adopt the updated revisions recommended by the Topical Optical Pharmaceutical Agents Committee. 6523752 12/19/2008
Vol. 34/51
View Text Development
64B13-18.002
To adopt the updated revisions recommended by the Topical Optical Pharmaceutical Agents Committee. 6367291 11/7/2008
Vol. 34/45
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 6241579 Effective:
10/16/2008
View Text Proposed
64B13-18.002
The purpose of the amendment is to incorporate a new medication requested by the Florida Optometric Association, to which the TOPA Committee did not raise an objection, and to implement the Board’s determination that Azasite .... 6007615 8/22/2008
Vol. 34/34
View Text Development
64B13-18.002
The purpose of the amendment is to incorporate a new medication requested by the Florida Optometric Association, to which the TOPA Committee did not raise an objection, and to implement the Board’s determination that Azasite .... 5915174 8/1/2008
Vol. 34/31
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 5762981 Effective:
06/26/2008
View Text Proposed
64B13-18.002
The purpose of the amendment is to add medications to the Formulary of Topical Ocular Pharmaceutical Agents at the request of the Florida Optometric Association as approved by the TOPA Committee Members. 5564325 5/2/2008
Vol. 34/18
View Text Development
64B13-18.002
The purpose and effect is to add medications to the Formulary of Topical Ocular Pharmaceutical Agents at the request of the Florida Optometric Association as approved by the TOPA Committee Members. 5497686 4/11/2008
Vol. 34/15
View Text Final
64B13-18.002
Formulary of Topical Ocular Pharmaceutical Agents 2454020 Effective:
06/10/2006
View Text Proposed
64B13-18.002
The Board proposes to update the existing language in this rule to add new pharmaceutical agents. 120782 3/3/2006
Vol. 32/09
View Text Development
64B13-18.002
The Board proposes to update the existing language in this rule to add new pharmaceutical agents. 78102 2/3/2006
Vol. 32/05